--2025/Q1-- / 0.000--
--2024/Q4-- / 0.000--
--2024/Q30.000 / 0.000--
--------
--------
Oracle
ORCL
NVIDIA
NVDA
Microsoft
MSFT
Meta Platforms
META
Salesforce
CRM
US Stock MarketDetailed Quotes
MBX MBX Biosciences
- 10.775
- +0.545+5.33%
Trading Jan 22 13:24 ET
360.08MMarket Cap-6.52P/E (TTM)
11.070High10.200Low80.58KVolume10.300Open10.230Pre Close866.08KTurnover0.79%Turnover RatioLossP/E (Static)33.42MShares27.50052wk High1.33P/B109.91MFloat Cap9.42452wk Low--Dividend TTM10.20MShs Float27.500Historical High--Div YieldTTM8.50%Amplitude9.424Historical Low10.747Avg Price1Lot Size
MBX Biosciences Key Stats
MBX Biosciences Earnings Estimates
Revenue
EPS
EBIT
Revenue is based on 1 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement
Currency: USD
Actual
Estimate
Unlock Free Earnings Estimates
Open Account
MBX Biosciences Earnings Reports
Trending Stocks
Fed Rate Cut Beneficiaries Fed Rate Cut Beneficiaries
Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data. Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data.
Analysis
Price Target
No Data
